Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Oral Communications

Diabetes 1

ea0063oc2.1 | Diabetes 1 | ECE2019

Every fifth patient with type 1 diabetes suffers from an additional endocrinological autoimmune disease – a finnish nationwide study

Makimattila Sari , Harjutsalo Valma , Forsblom Carol , Groop Per-Henrik

Autoimmune diseases tend to coexist in the same subjects and are more often present in women than in men. Finland has the highest incidence of type 1 diabetes (TID). However, the coexistence of autoimmune diseases and excess risk compared to individuals without T1D in unknown. This study compares the proportion of autoimmune hypothyreosis and hyperthyreosis, Addison’s disease and celiac disease in adults in Finland with and without T1D. The study included 4,758 patients w...

ea0063oc2.2 | Diabetes 1 | ECE2019

Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission

Liu Qiaoran , Huang Xin , Cheng Yugang , Liu Teng , Zhong Mingwei , Zhang Guangyong , Hu Sanyuan , Liu Shaozhuang

Background: Bariatric surgery can profoundly ameliorate hyperglycemia and improve insulin sensitivity thus contribute to diabetes remission. However the detailed mechanisms underlying this effect is yet to be revealed. The aim of this research is to investigate the metabolic alterations in skeletal muscle after bariatric surgery and explore the possible mechanisms to further explain the diabetes remission effect of bariatric surgery.Methods: Duodenal-jej...

ea0063oc2.3 | Diabetes 1 | ECE2019

Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes

Ghosh Chiranjit , Pradhan Manik

Background: There is a pressing need to develop a new and an effective strategy for early detection of T1D and to precisely distinguish T1D from type 2 diabetes (T2D). The aim of the present study was to find out the potential link between the erythrocytes carbonic anhydrase (CA) activity and 18O-isotopic exchange of breath CO2 in T1D and T2D.Methods: Fasting and post-dose breath and blood samples were collected simultaneously after...

ea0063oc2.4 | Diabetes 1 | ECE2019

Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice

Dimitriadis Georgios K , Nasiri-Ansari Narjes , Agrogannis Georgios , Nikiteas Nikolaos , Kostakis Ioannis D , Kaltsas Gregory , Papavassiliou Athanasios G , Kassi Eva , Randeva Harpal S

Background: Sodium glucose co-transporter 2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with empagliflozin on biochemical and immunohistochemical markers related to atherosclerosis development in apolipoprotein E knockout [Apo-E(−/−)] mice.Methods: At the ag...

ea0063oc2.5 | Diabetes 1 | ECE2019

5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo

Harris Shelley , Nikolaou Nikolaos , Arvaniti Anastasia , Cox Roger , Gathercole Laura , Tomlinson Jeremy

The enzyme 5β-reductase (AKR1D1) catalyses an essential step in bile acid synthesis, but in addition, controls intra-cellular steroid hormone availability by generating 5β-reduced dihydrosteroid metabolites. As disturbances in steroid hormone and bile acid metabolism have potent effects on metabolic health and lipid homeostasis, we hypothesize that AKR1D1 may play a role hepatic lipid accumulation and contribute to the development of metabolic disease. We generated a...